UChicago and Duality Teams to perform at Chicago Venture Summit 2021



Published on

Several teams from the University of Chicago and Duality – the world’s first accelerator exclusively focused on quantum technologies – are showing up in 2021 Chicago Corporate Summit.

The venture capital conference takes place September 27-29 and brings together leading venture capitalists and innovation ecosystem leaders with founders.

>> Register for the Deep Tech Showcase, here.

Launching the conference on Monday, September 27, the Polsky Center for Entrepreneurship and Innovation and the Chain Reaction Innovations program in Argonne are welcoming the 2021 Deep Tech Showcase as part of a larger event. The virtual showcase is from 2:00 p.m. to 3:30 p.m. (CST).

The pitches of the UChicago and Duality teams include:

// AddGraft Therapeutics is developing a therapeutic technology based on CRISPR using skin cells to treat addiction. Researchers have developed a therapeutic platform that, through a unique and one-of-a-kind treatment, will effectively cure someone of alcohol use disorder (AUD). The treatment is long lasting, very effective and minimally invasive.

This is supplemented by using epidermal progenitor cells from the skin to deliver one or more therapeutic agents. First, the researchers harvest skin stem cells from an AUD patient and genetically modify them using a precise molecular CRISPR chisel. This process will introduce genes capable of producing molecules that will significantly reduce the motivation to consume or seek alcohol. Then, they re-implant these skin cells into the original host through a skin graft. Once the graft is reimplanted, the skin graft is able to produce these molecules as a biomotor throughout the life of the graft.

Members of the team:

  • Ryan meyers, MBA ’22, co-founder and CEO
  • Xiaoyang wu, Co-Founder and Chief Technology Officer, Associate Professor, Division of Biological Sciences, University of Chicago
  • Ming Xu, Co-Founder and Scientific Director, Professor of Anesthesia and Critical Care, Division of Biological Sciences, University of Chicago

// Immune to arrows develops next-generation biologics for immuno-oncology in solid tumors. The company is developing protein engineering technology to conserve IO molecules in the tumor microenvironment, both to function as monotherapies and to enhance the response to checkpoint inhibitor immunotherapy.

The company has developed a powerful approach to mask these compounds so that they are inactive at the periphery but activated within the tumor, in order to limit adverse events linked to the immune system and to open the therapeutic window.

Members of the team:

  • Jeffrey Hubbell, Co-Founder, Eugene Bell Professor of Tissue Engineering and Associate Dean of Development, University of Chicago
  • June Ishihara, co-founder, lecturer, Imperial College London
  • Aslan Mansurov, co-founder, postdoctoral researcher, University of Chicago
  • Melody Swartz, Co-Founder, William B Ogden Professor of Molecular Engineering, University of Chicago

// Axion Technologies is a Tallahassee, Florida-based company that develops a quantum random number generator for high performance computer systems. Its design allows the integration of unique digital signatures for hardware authentication. The company received an NSF SBIR award.

Members of the team:

  • Carol scarlett, Founder, Assistant Professor of Physics at Florida A&M University

// Esya Labs’ mission is the early, accurate and cost-effective detection of neurodegenerative diseases. Its premier product for Alzheimer’s disease will offer a 360-degree perspective for early diagnosis, a personalized treatment plan based on the effectiveness of drugs classified for a given patient, and monitoring of disease progression.

The platform uses synthetic DNA strands that have been designed to work in a specific way. These so-called “DNA nanodevices”Are used to measure the performance of lysosomes by creating chemical maps of their activity – a process that was not possible before. The company in

Members of the team:

// Nanomed technologies markets quantum dot ink that enables the manufacture of the next generation of low power, bright, and fast refresh rate displays – and recently received a $ 1 million NSF SBIR grant.

In addition to displays, NanoPattern’s patented technology is able to model oxide nanoparticles for optical applications and near infrared (NIR) quantum dots for multispectral sensor applications.

Members of the team:

  • Yu kambe, PhD ’19, co-founder and CEO
  • Dmitri Talapin, co-founder, Ernest DeWitt Burton Distinguished Service Professor in the Department of Chemistry

// q Braid is a Hanover, NH-based company developing a cloud-based platform for managed access to other quantum computing software and hardware. The platform includes qBraid Learn and qBraid Lab.

qBraid Learn is ready to host all courses developed by the quantum computing ecosystem, but the team has also developed its own educational content. qBraid offers a streamlined experience for first-time learners with its QuBes (Quantum Beginners) course. Hosted on the qBraid-learn platform, QuBes introduces students to all the basic knowledge (mathematics, coding and physics) needed to then introduce quantum computing.

qBraid Lab provides a cloud-based Integrated Development Environment (IDE) for quantum software developers. Unlike other browser-integrated development platforms, the qBraid ecosystem specifically optimizes quantum computing by providing development environments with all popular quantum computing packages preinstalled.

Members of the team:

// Quantopticon, based in the United Kingdom, is developing software for simulating quantum photonic devices. The software finds applications primarily in the emerging fields of quantum computing and ultra-secure quantum communications.

Quantopticon specializes in the modeling of solid-type quantum systems, which are commonly integrated into cavity structures in order to control and improve specific optical transitions. Its software for modeling the interactions of light with matter is based on an original and proprietary general methodology developed by the team from first principles.

The goal of their software is ultimately to save quantum optics designers time and money by eliminating the need to perform repeated experiments to test and optimize physical prototypes.

Members of the team:

// Super.tech develops software that accelerates quantum computing applications by optimizing the entire system stack, from algorithms to control pulses. The company in August announcement the launch of a software platform striving to make quantum computing commercially viable years earlier than possible.

The platform, called SuperstaQ, connects applications to quantum computers from IBM Quantum, IonQ and Rigetti, and optimizes software across the entire system stack to improve the performance of underlying quantum computers.

Members of the team:

  • Fred chong, Co-Founder and Chief Scientist, Seymour Goodman Professor in the Department of Computer Science at the University of Chicago
  • Pranav Gokhalé, PhD ’20, co-founder and CEO

Among the featured teams, Axion, qBraid, Quantopticon and Super.tech were selected from a competitive pool of applicants from around the world and screened through an internal review process to participate in duality Cohort 1.

Launched in April 2021, Duality is the first accelerator of its kind to support next-generation startups focused on quantum science and technology. The 12-month program provides world-class training in business and entrepreneurship from the University of Chicago Booth School of Business, Polsky Center, and the ability to engage the networks, facilities and programming of the Chicago Quantum Exchange, the University of Illinois Urbana-Champaign, Argonne National Laboratory, and P33.


Leave A Reply

Your email address will not be published.